SCHEMBL5597754

SCHEMBL5597754

COc1ccc(F)cc1CNC(=O)CCl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA7 P43166 1/20 0.55
CA9 Q16790 1/20 0.55
POLB P06746 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.50
ALDH1A1 P00352 2/20 0.50
HTT P42858 2/20 0.49
HPGD P15428 2/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
ANO1 Q5XXA6 1/20 0.48
ANO2 Q9NQ90 1/20 0.48
GAA P10253 1/20 0.47
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31248400 0.83 HPGD (0.68) POLBSMN1; SMN2ALDH1A1HTTHPGD
SCHEMBL20738484 0.83 MTNR1A (0.53) POLBSMN1; SMN2ALDH1A1HPGDGAA
SCHEMBL4033108 0.81 CNR1 (0.52) CA1CA2CA7CA9ALDH1A1
SCHEMBL5598110 0.81 PPARG (0.50) CA1CA2CA7CA9SMN1; SMN2
SCHEMBL4032263 0.78 P2RX7 (0.53) MEN1KMT2ALMNATP53P2RX7
SCHEMBL24713929 0.77 SMN1; SMN2 (0.57) POLBSMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL2223385 0.77 ALDH1A1 (0.59) CA1CA2CA7CA9POLB
SCHEMBL20456221 0.76 ALDH1A1 (0.71) POLBSMN1; SMN2ALDH1A1HTTMEN1
SCHEMBL23417636 0.75 CA1 (0.57) CA1CA2CA7CA9POLB
SCHEMBL26622064 0.75 MTNR1A (0.54) SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1815860-A2 Phosphate transport inhibitors GENZYME CORPORATION (US) 2007-08-08 EP disclosed
EP-1815860-A2 Phosphate transport inhibitors GENZYME CORPORATION (US) 2007-08-08 EP disclosed
EP-1465638-B1 PHOSPHATE TRANSPORT INHIBITORS GENZYME CORP (US) 2007-05-16 EP disclosed
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 US disclosed
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 US disclosed
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 US disclosed
US-7119120-B2 Phosphate transport inhibitors GENZYME CORPORATION (US) 2006-10-10 US disclosed
EP-1465638-A2 PHOSPHATE TRANSPORT INHIBITORS GENZYME CORPORATION (US) 2004-10-13 EP disclosed
US-20040019113-A1 Phosphate transport inhibitors GELTEX PHARMACEUTICALS, INC. 2004-01-29 US disclosed
WO-2003057225-A2 PHOSPHATE TRANSPORT INHIBITORS GENZYME CORPORATION (US) 2003-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040019113-A1 Phosphate transport inhibitors SLC34A1, SLC34A2, SLC20A1 CA1 2722/4885CA2 232/4885CA7 1143/4885
US-20070021509-A1 Phosphate transport inhibitors SLC34A2, SLC34A1, SLC20A1 CA1 2476/4885CA2 215/4885CA7 1314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.